Search results for {QUERY}

Legend

0 items
copaxone
 
 
No product results found.

Pages

(50)

Mylan Invalidates Third Teva Copaxone® 40 mg/mL Patent ...

… Press Releases. Mylan Invalidates Third Teva Copaxone® 40 mg/mL Patent
Via US Patent and Trademark Office's Inter Partes Review Proceeding. …

Mylan Comments on Copaxone® Ruling - Jun 25, 2012

… Print. Press Releases. Mylan Comments on Copaxone® Ruling. 2012 Earnings
Guidance and 2013 Earnings Targets Remain Unchanged. …

Court of Appeals Ruling on Teva Copaxone® Patent Allows ...

… Sheets. Print. Press Releases. Court of Appeals Ruling on Teva
Copaxone® Patent Allows Mylan May 2014 Launch. PR …

Teva and Mylan Settle Copaxone® Patent Litigation in France ...

… Print. Press Releases. Teva and Mylan Settle Copaxone® Patent Litigation
in France, the UK and the Netherlands. PITTSBURGH, Nov. …

Mylan Wins US District Court Ruling Related to Copaxone® ...

… Print. Press Releases. Mylan Wins US District Court Ruling Related
to Copaxone® 40 mg/mL Patents. HERTFORDSHIRE …

US Court of Appeals for the Federal Circuit Finds Teva's '808 ...

… Sheets. Print. Press Releases. US Court of Appeals for the Federal Circuit
Finds Teva's '808 Copaxone® Patent Invalid. Ruling …

Mylan's ANDA for Three Times Per Week Generic Copaxone® ...

… Print. Press Releases. Mylan's ANDA for Three Times Per Week Generic
Copaxone® 40 mg/mL Accepted for Filing by FDA. PITTSBURGH, Aug. …

US Supreme Court Partially Modifies Standard of Review of ...

… Court Partially Modifies Standard of Review of Patent Claim Construction and
Remands Review of Teva's '808 Patent on Copaxone® to Federal …